How Lilly Looks to Bring New Treatment Approaches for People with Type 2 Diabetes

Worldwide, more than half a billion people have diabetes. In the U.S., it’s more than 37 million - and 9 out of 10 have type 2 diabetes, a complex disease where the body doesn’t use energy from food properly.

Despite the many treatment advancements in recent years, only half of the people living with diabetes are meeting goals for lowering their blood glucose levels. When glucose is not properly managed, it may lead to serious complications, including kidney disease, nerve damage, heart attack and stroke.

The needs of people with type 2 diabetes continue to evolve over time, and treatment approaches need to reflect that. Lilly's cutting-edge research is focused on disrupting the progression of the disease to improve care and outcomes - allowing people with diabetes to live full, active and healthy lives.

Watch here to learn more about how Lilly looks to bring new treatment approaches for people with Type 2 diabetes.

Lilly is a 2023 National Strategic Partner of DiabetesSisters. DiabetesSisters shares information they provide that is useful to our community; however, the relationship does not influence the decisions or opinions of DiabetesSisters, its governing board, or its staff.